Evaluation License Term definition

Evaluation License Term means the term of the Evaluation License as set forth in the Section 12.1.
Sample 1Sample 2Sample 3
Evaluation License Term means, with respect to an Evaluation License, the license period encoded in the evaluation license key provided by Cloudian to Licensee for such Evaluation License; provided, however, that if, prior to the end of such period, a production license key is installed on any node of the Cloudian-Powered Storage System covered by such evaluation license key, the Evaluation License Term will terminate upon such installation of such production license key. For avoidance of doubt, there will be no Evaluation License Term for any Cloudian Product unless and until an evaluation license key is provided by Cloudian to Licensee for such Cloudian Product.
Sample 1Sample 2

Examples of Evaluation License Term in a sentence

  • If licensee exercises its option(s) to renew the Evaluation License Term pursuant to Section 12.1 of this Agreement, then Licensee agrees to pay ATCC a renewal payment in the amount of Five Thousand Dollars ($5,000) for each such twelve month renewal.

  • For purposes that are in addition to or other than those set forth in Section 1.13, Licensee has not license under this Agreement during the Evaluation License Term; and any such use of ATCC Materials that falls outside the scope of the Evaluation Purpose during the Evaluation License Term shall be governed by the terms of the MTA.

  • Unless extended by RTI, the Evaluation License Term concludes thirty (30) days from the date of Licensee’s first download or installation of the Software.

  • Such payment shall be made no later than thirty (30) days after the expiration of the Evaluation License Term; provided, however, that any fees paid pursuant to Section 4.1(a) shall be credited towards and applied to the Initiation Fee.

  • Subject to the terms and conditions of this Agreement (including Section 3), Cloudian hereby grants to Licensee a non-exclusive, non-transferable (except as permitted in Section 12.3), non-sublicensable license to do the following during the license period (i.e., the Evaluation License Term or Production License Term) of each Software License: make and use a reasonable number of copies of the Documentation for the applicable Cloudian Product solely in connection with the permitted use thereof.

  • This paragraph will not apply if such unit is purchased by Licensee prior to the end of such Evaluation License Term or Appliance Return Period.

  • Any inquiries to acquire licenses to the Software once the Evaluation License Term has expired shall be made to xxxxxxxxx@xxxxxxxx.xxx.

Related to Evaluation License Term

  • License Term means the duration of a License as specified in the Order.

  • License Period means the period beginning from the Commencement Date and ending on the Termination Date.

  • Research License means a nontransferable, nonexclusive license to make and to use the Licensed Products or the Licensed Processes as defined by the Licensed Patent Rights for purposes of research and not for purposes of commercial manufacture or distribution or in lieu of purchase.

  • Collaboration Term has the meaning set forth in Section 2.1(h).

  • Regulatory Exclusivity Period means, with respect to each Licensed Product in any country in the Territory, a period of exclusivity (other than Patent exclusivity) granted or afforded by Applicable Law or by a Regulatory Authority in such country that confers exclusive marketing rights with respect to such Licensed Product in such country or prevents another Person from using or otherwise relying on any data supporting the approval of the Drug Approval Application for such Licensed Product to support an application for regulatory approval of another product for any indication without the prior written consent of the Drug Approval Application holder.

  • Research Program Term has the meaning set forth in Section 2.2.

  • Collaboration Know-How means all Know-How conceived, discovered, developed or otherwise made by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing (solely or jointly by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing) in the course of [***].

  • Generation Licence means an electricity generation licence granted or treated as granted pursuant to section 6(1)(a) of the EA 1989 that authorises a person to generate electricity;

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Massive Multiauthor Collaboration Site (or “MMC Site”) means any World Wide Web server that publishes copyrightable works and also provides prominent facilities for anybody to edit those works. A public wiki that anybody can edit is an example of such a server. A “Massive Multiauthor Collaboration” (or “MMC”) contained in the site means any set of copyrightable works thus published on the MMC site.

  • Research Use shall have the meaning given in Section 2.2.2 of this Agreement.

  • Licence Term means the Initial Term plus any Further Term; Licensee means You and/or the Permitted Users;

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • License Key means a unique key-code that enables Licensee to run Software subject to the obtained User Pack.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Technology License Agreement means the agreement in the form of Exhibit H hereto.

  • Research Term has the meaning set forth in Section 3.2.

  • Royalty Term means, on a country-by-country basis, the period commencing on the First Commercial Sale of a Licensed Product in a country and ending on the latest of (a) ** thereafter, (b) expiration of the last-to-expire Valid Claim of a Licensed Patent that Covers the composition of matter of the Licensed Product in the country in which it is sold, or (c) the expiration of all Regulatory Exclusivity Rights with respect to such Licensed Product in the country in which it is sold.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Development Consent means the consent granted to the Development Application for the Development and includes all modifications made under section 4.55 of the Act.

  • Phase IV Clinical Trial means a product support clinical trial of a Product commenced after receipt of Regulatory Approval in the country where such trial is conducted. A Phase IV Clinical Trial may include epidemiological studies, modeling and pharmacoeconomic studies, and investigator-sponsored clinical trials studying Product that are approved by the JDC and that otherwise fit the foregoing definition.

  • Development approval means a document from a governmental entity which authorizes the commencement of a development.